aspirin has been researched along with isradipine in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (58.82) | 18.2507 |
| 2000's | 4 (23.53) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Angelberger, P; Gerakakis, A; Keiler, A; Lupattelli, G; Pirich, C; Sinzinger, H; Virgolini, I | 1 |
| Angelberger, P; Keiler, A; Lupattelli, G; Molinari, E; O'Grady, J; Sinzinger, H; Virgolini, I | 1 |
| Fitscha, P; Keiler, A; O'Grady, J; Rauscha, F; Sinzinger, H | 2 |
| Keiler, A; O'Grady, J; Sinzinger, H | 1 |
| Fetkovska, N; Jakubovska, Z; Oravcova, J; Tison, P; Ulicna, L | 2 |
| Rogatti, W; Sinzinger, H | 1 |
| Fetkovska, N; Jakubovska, Z; Oravcova, J; Tison, P; Trnovec, T; Ulicna, L | 1 |
| Belenkov, IuN; Chazova, IE; Lazutkina, VK; Martyniuk, TV; Masenko, VP | 1 |
1 review(s) available for aspirin and isradipine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for aspirin and isradipine
| Article | Year |
|---|---|
Effects of dihydropyridines and their combination with aspirin on blood pressure and circadian platelet activity in patients with essential hypertension.
Topics: Adult; Aspirin; Blood Platelets; Blood Pressure; Circadian Rhythm; Dihydropyridines; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Isradipine; Male; Middle Aged; Nitrendipine | 1994 |
Treatment of hypertension with dihydropyridine calcium antagonists and aspirin.
Topics: Adult; Aspirin; Blood Platelets; Blood Pressure; Calcium Channel Blockers; Circadian Rhythm; Dihydropyridines; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Isradipine; Male; Middle Aged; Nitrendipine | 1994 |
Treatment of hypertension with calcium antagonists and aspirin. Effects on 24-h platelet activity.
Topics: Adult; Aspirin; Circadian Rhythm; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Isradipine; Male; Middle Aged; Nitrendipine; Platelet Aggregation; Treatment Outcome | 1993 |
13 other study(ies) available for aspirin and isradipine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Concomitant aspirin treatment abolishes the antiatherosclerotic effects of the calcium channel blocker isradipine mediated by PGI2.
Topics: Animals; Aorta, Abdominal; Arteriosclerosis; Aspirin; Calcium Channel Blockers; Cholesterol; Dihydropyridines; Epoprostenol; Humans; Hypercholesterolemia; Isradipine; Kinetics; Lipid Metabolism; Lipoproteins, LDL; Male; Rabbits | 1992 |
Aspirin abolishes the decreased low-density lipoprotein (LDL) entry into the rabbit arterial wall induced by the calcium channel blocker isradipine.
Topics: Animals; Aspirin; Calcium Channel Blockers; Cholesterol; Endothelium, Vascular; Epoprostenol; Isradipine; Lipoproteins, LDL; Male; Rabbits | 1992 |
The diminished extracellular matrix production induced by isradipine, a calcium channel blocker, is completely abolished by cyclooxygenase inhibition.
Topics: Animals; Arteriosclerosis; Aspirin; Calcium Channel Blockers; Collagen; Cyclooxygenase Inhibitors; Dihydropyridines; Drug Interactions; Epoprostenol; Extracellular Matrix; Glycosaminoglycans; Isradipine; Male; Rabbits | 1992 |
Arterial wall rather than platelets is responsible for diminished thrombogenicity during isradipine therapy.
Topics: Animals; Arteries; Aspirin; Blood Platelets; Endothelium, Vascular; Epoprostenol; Humans; In Vitro Techniques; Indium Radioisotopes; Isradipine; Male; Perfusion; Rabbits; Thrombosis; Thromboxane B2 | 1995 |
Prostaglandins and arterial wall lipid metabolism--in vitro, ex-vivo and in-vivo radioisotopic studies.
Topics: Alprostadil; Animals; Arteries; Aspirin; Cholesterol; Cyclic AMP; Epoprostenol; Humans; In Vitro Techniques; Iodine Radioisotopes; Isradipine; Kinetics; Lipid Metabolism; Lipids; Lipoproteins, LDL; Male; Prostaglandin Antagonists; Prostaglandins; Prostaglandins E, Synthetic; Rabbits | 1994 |
Isradipine inhibits mitotic and proliferative activity in the arterial wall.
Topics: Animals; Arteries; Aspirin; Cell Division; Cholesterol; Desoxycorticosterone; Epoprostenol; Humans; Isradipine; Male; Mitosis; Rabbits; Thymidine | 1994 |
[The use of aspirin in patients with primary pulmonary hypertension].
Topics: Adult; Alprostadil; Aspirin; Calcium Channel Blockers; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hypertension, Pulmonary; Isradipine; Male; Platelet Aggregation Inhibitors; Time Factors; Vasodilator Agents | 1998 |